CClinicalTrials.gg
Not yet recruitingNCT07460024Updated Mar 10, 2026

Implementation of Timely Management of Sepsis and Septic Shock Protocol in the Emergency Department and Intensive Care Unit: A Quality Improvement Project at AFHJ

An interventional study of Adapted Surviving Sepsis Campaign (SSC) Protocol and Standard Clinical Care in Sepsis, Septic Shock and Systemic Inflammatory Response Syndrome (SIRS), sponsored by Al-Azhar University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Study Title: Implementation of a Sepsis Management Protocol at Armed Forces Hospital Jazan (AFHJ).

Purpose: The purpose of this quality improvement project is to determine if implementing a standardized, evidence-based "sepsis bundle" can improve the care and survival of patients with sepsis and septic shock in the Emergency Department (ED) and Intensive Care Unit (ICU).

What the Study Involves:

Researchers will implement a specific set of clinical guidelines based on the international Surviving Sepsis Campaign. This include:

Using a scoring system (NEWS2 and SOFA) to identify sick patients earlier.

Ensuring patients receive five critical treatments (the "one-hour bundle") within 60 minutes of diagnosis, including blood tests, IV fluids, and antibiotics.

Comparison:

The study will compare the outcomes of 74 patients treated before the protocol was introduced (the "Pre-protocol group") to 46 patients treated after the new protocol was put into effect (the "Protocol group").

Expected Outcome:

The goal is to increase the number of patients who receive all necessary treatments within one hour from less than 15% to at least 60%. The study also aims to see if this protocol leads to shorter hospital stays and lower mortality rates.

Read the detailed description

Project Overview Sepsis and septic shock represent a significant global health burden, characterized by life-threatening organ dysfunction resulting from a dysregulated host response to infection. Clinical outcomes are heavily dependent on the speed of recognition and the initiation of evidence-based interventions. This quality improvement (QI) project was designed to address gaps in the timely management of sepsis at the Armed Forces Hospital Jazan (AFHJ) by implementing a standardized clinical protocol in the Emergency Department (ED) and Intensive Care Unit (ICU).

Protocol Framework

The intervention is based on an adaptation of the international Surviving Sepsis Campaign (SSC) guidelines. The protocol integrates two validated scoring systems to enhance diagnostic accuracy and urgency:

National Early Warning Score 2 (NEWS2): Utilized for the initial screening of patients to identify physiological deterioration early.

Sequential Organ Failure Assessment (SOFA): Used to formally assess and track the degree of organ dysfunction.

The One-Hour Bundle Intervention

The core of the clinical intervention is the "One-Hour Bundle," which mandates that five key actions be initiated within 60 minutes of sepsis recognition:

Lactate Measurement: To identify tissue hypoperfusion (repeated if initial lactate is >2 mmol/L).

Microbiological Diagnostics: Obtaining blood cultures prior to the administration of antimicrobial agents to ensure targeted therapy later.

Empiric Antimicrobials: Rapid administration of broad-spectrum antibiotics to combat the underlying infection.

Fluid Resuscitation: Immediate infusion of 30 mL/kg of crystalloid for patients presenting with hypotension or high lactate levels.

Vasopressor Support: Application of vasopressors (typically norepinephrine) if the patient remains hypotensive during or after fluid resuscitation to maintain a Mean Arterial Pressure (MAP) of ≥65 mm Hg.

Implementation Strategy

The project utilized a multi-disciplinary approach involving consultants from Anesthesiology, ICU, and Surgery, alongside nursing leadership and medication safety officers. Implementation was supported by:

Educational Workshops: Training frontline staff on NEWS2 and SOFA scoring.

Visual Aids: Strategic placement of the sepsis algorithm in high-acuity areas.

Quality Oversight: Continuous monitoring of compliance through data collection sheets to identify and remove systemic barriers to rapid care.

Study Methodology The project followed a quasi-experimental pre-post intervention design. The Pre-protocol phase involved a retrospective review of cases to establish a baseline of care compliance and patient outcomes. The Protocol phase involved the prospective enrollment of patients following the formal introduction of the new guidelines. By standardizing the "time to antibiotics" and "time to fluid bolus," the study aimed to demonstrate that protocolized care directly correlates with reduced Intensive Care Unit (ICU) and hospital Length of Stay (LOS), as well as a significant reduction in sepsis-related mortality rates.

02

Conditions studied

  • Sepsis
  • Septic Shock
  • Systemic Inflammatory Response Syndrome (SIRS)
  • Critical Illness
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients aged 18 years or older.
  • Clinical suspicion of sepsis or a confirmed diagnosis of sepsis upon admission to the Emergency Department (ED) or Intensive Care Unit (ICU).
  • Presence of symptoms meeting the criteria for the sepsis management protocol during the study period.

Exclusion criteria

Exclusion Criteria:

  • Patients transferred from other healthcare facilities after sepsis treatment had already been initiated.
  • End-of-life cases or patients with "Do Not Attempt Resuscitation" (DNAR) status where data sets are incomplete.
  • Cases with insufficient medical documentation that prevents accurate outcome measurement or bundle compliance tracking.
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Placebo comparator
    Pre-protocol Group (Baseline)

    his retrospective cohort includes 74 adult patients with suspected sepsis or septic shock treated at AFHJ between January and December 2024. This arm represents the "standard of care" prior to the formal implementation of the adapted sepsis management protocol.

    Other: Standard Clinical Care

  • Experimental
    Protocol Group (Intervention)

    his prospective cohort includes 46 adult patients with suspected sepsis or septic shock treated at AFHJ between January and July 2025. These patients were managed according to a structured sepsis protocol involving early screening (NEWS2/SOFA) and the "one-hour bundle."

    Other: Adapted Surviving Sepsis Campaign (SSC) Protocol

Interventions

  • OtherAdapted Surviving Sepsis Campaign (SSC) Protocol

    A multi-component clinical management strategy focusing on early recognition and rapid treatment. Key elements include: Screening: Use of National Early Warning Score 2 (NEWS2) at triage. Diagnosis: Use of Sequential Organ Failure Assessment (SOFA) to identify organ dysfunction. The One-Hour Bundle: Execution of five tasks within 60 minutes: (1) Measuring lactate, (2) Obtaining blood cultures, (3) Administering broad-spectrum antibiotics, (4) IV fluid resuscitation (30 mL/kg) for hypotension or high lactate, and (5) Vasopressors to maintain MAP ≥ 65 mmHg.

  • OtherStandard Clinical Care

    Traditional sepsis management as practiced at the institution prior to the implementation of the standardized QI protocol. This care was characterized by inconsistent bundle compliance and variable timing of antibiotic administration and fluid resuscitation.

05

What researchers measure

Primary outcomes

  1. Compliance rate with the full 5-item Sepsis One-Hour Bundle.

    The percentage of patients who received all five components of the adapted Surviving Sepsis Campaign (SSC) bundle within 60 minutes of "Time Zero" (triage or recognition). The five components are: 1. Lactate measurement, 2. Blood cultures, 3. Broad-spectrum antibiotics, 4. 30 mL/kg crystalloid fluid, and 5. Vasopressors (if indicated).

    Time frame: Within 1 hour of sepsis recognition (Time Zero).

Secondary outcomes

  1. Length of Stay (LOS) in the Intensive Care Unit (ICU).

    The duration of stay in the ICU measured in days. This measure evaluates if the timely implementation of the sepsis bundle leads to faster clinical stabilization and earlier discharge from critical care.

    Time frame: From ICU admission to ICU discharge (average 5-7 days).

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07460024
Lead sponsor
Al-Azhar University
Responsible party
Tarik Saber Sarhan (Associate Professor Doctor, Al-Azhar University) — Principal investigator
First posted
Mar 10, 2026
Start date
Mar 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Mar 10, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion